BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27195776)

  • 1. Bloodstream-To-Eye Infections Are Facilitated by Outer Blood-Retinal Barrier Dysfunction.
    Coburn PS; Wiskur BJ; Miller FC; LaGrow AL; Astley RA; Elliott MH; Callegan MC
    PLoS One; 2016; 11(5):e0154560. PubMed ID: 27195776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-Retinal Barrier Compromise and Endogenous Staphylococcus aureus Endophthalmitis.
    Coburn PS; Wiskur BJ; Astley RA; Callegan MC
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7303-11. PubMed ID: 26559476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis.
    Coburn PS; Wiskur BJ; Christy E; Callegan MC
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7426-31. PubMed ID: 23036996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
    Xu HZ; Le YZ
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2160-4. PubMed ID: 21178141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Candida albicans Infection in Mice Causes Endogenous Endophthalmitis via Breaching the Outer Blood-Retinal Barrier.
    Singh S; Singh S; Kumar A
    Microbiol Spectr; 2022 Aug; 10(4):e0165822. PubMed ID: 35913202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy.
    Jo DH; Yun JH; Cho CS; Kim JH; Kim JH; Cho CH
    Glia; 2019 Feb; 67(2):321-331. PubMed ID: 30444022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis.
    Moyer AL; Ramadan RT; Novosad BD; Astley R; Callegan MC
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3783-93. PubMed ID: 19264886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
    Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
    Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-retinal barrier.
    Cunha-Vaz J; Bernardes R; Lobo C
    Eur J Ophthalmol; 2011; 21 Suppl 6():S3-9. PubMed ID: 23264323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
    Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
    J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections.
    Coburn PS; Miller FC; LaGrow AL; Land C; Mursalin H; Livingston E; Amayem O; Chen Y; Gao W; Zhang L; Callegan MC
    mSphere; 2019 May; 4(3):. PubMed ID: 31092603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy.
    Fu D; Yu JY; Connell AR; Hookham MB; McLeese RH; Lyons TJ
    J Ocul Pharmacol Ther; 2020 Dec; 36(10):754-764. PubMed ID: 33107777
    [No Abstract]   [Full Text] [Related]  

  • 15. Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.
    Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
    Histochem J; 1993 Sep; 25(9):648-63. PubMed ID: 8226103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.
    Desjardins DM; Yates PW; Dahrouj M; Liu Y; Crosson CE; Ablonczy Z
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2706-13. PubMed ID: 27191823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction.
    Scuderi S; D'Amico AG; Castorina A; Imbesi R; Carnazza ML; D'Agata V
    Peptides; 2013 Jan; 39():119-24. PubMed ID: 23220033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decorin Prevents Retinal Pigment Epithelial Barrier Breakdown Under Diabetic Conditions by Suppressing p38 MAPK Activation.
    Wang S; Du S; Wu Q; Hu J; Li T
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):2971-9. PubMed ID: 25829413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood-retinal barriers.
    Cunha-Vaz JG
    Doc Ophthalmol; 1976 Oct; 41(2):287-327. PubMed ID: 1009819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats.
    Berkowitz BA; Roberts R; Luan H; Peysakhov J; Mao X; Thomas KA
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2391-8. PubMed ID: 15223822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.